CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Placentophagy

Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis. 📎

Written by CYBERMED LIFE NEWS
Attachments:
Download this file (Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis..pdf)Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis..pdf[Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.]1308 kB
facebook Share on Facebook
Abstract Title:

Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.

Abstract Source:

PLoS One. 2012 ;7(4):e35758. Epub 2012 Apr 26. PMID: 22563398

Abstract Author(s):

Yu Han Liu, Vijesh Vaghjiani, Jing Yang Tee, Kelly To, Peng Cui, Ding Yuan Oh, Ursula Manuelpillai, Ban-Hock Toh, James Chan

Article Affiliation:

Centre for Inflammatory Diseases, Department of Medicine, Monash University, Clayton, Victoria, Australia.

Abstract:

Human amniotic epithelial cells (hAEC) have stem cell-like features and immunomodulatory properties. Here we show that hAEC significantly suppressed splenocyte proliferation in vitro and potently attenuated a mouse model of multiple sclerosis (MS). Central nervous system (CNS) CD3(+) T cell and F4/80(+) monocyte/macrophage infiltration and demyelination were significantly reduced with hAEC treatment. Besides the known secretion of prostaglandin E2 (PGE2), we report the novel finding that hAEC utilize transforming growth factor-β (TGF-β) for immunosuppression. Neutralization of TGF-β or PGE2 in splenocyte proliferation assays significantly reduced hAEC-induced suppression. Splenocytes from hAEC-treated mice showed a Th2 cytokine shift with significantly elevated IL-5 production. While transferred CFSE-labeled hAEC couldbe detected in the lung, none were identified in the CNS or in lymphoid organs. This is the first report documenting the therapeutic effect of hAEC in a MS-like model and suggest that hAEC may have potential for use as therapy for MS.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.